this week this stock must be boughtSamsung organic is in a configuration that gives us a 90% chance of being right if we buy now
SAMSUNG BIOLOGICS Co., Ltd.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
34,000 KRW
1.08 T KRW
4.55 T KRW
23.87 M
About SAMSUNG BIOLOGICS Co., Ltd.
Sector
Industry
CEO
John Chongbo Rim
Website
Headquarters
Inchon
Founded
2011
IPO date
Nov 10, 2016
IPO offer price
118.86 USD
Identifiers
2
ISINKR7207940008
SAMSUNG BIOLOGICS Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services for pharmaceutical products. It operates through the CDMO and Biopharmaceutical Development and Commercialization business divisions. The CDMO division provides development services from cell line development to early clinical trials, including cell line development, processes, formulations, and analysis methods. The Biopharmaceutical Development and Commercialization division focuses on the development and commercialization of biosimilars and is conducting research and development on various disease fields such as autoimmune diseases, cancer diseases, ophthalmic diseases, and blood diseases. The company was founded on April 22, 2011 and is headquartered in Incheon, South Korea.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 207940 is featured.
Frequently Asked Questions
The current price of 207940 is 1,733,000 KRW — it has decreased by −0.29% in the past 24 hours. Watch SAMSUNG BIOLOGICS Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SAMSUNG BIOLOGICS Co., Ltd. stocks are traded under the ticker 207940.
207940 stock has risen by 3.22% compared to the previous week, the month change is a −9.67% fall, over the last year SAMSUNG BIOLOGICS Co., Ltd. has showed a 16.73% increase.
We've gathered analysts' opinions on SAMSUNG BIOLOGICS Co., Ltd. future price: according to them, 207940 price has a max estimate of 3,075,763.96 KRW and a min estimate of 1,913,268.71 KRW. Watch 207940 chart and read a more detailed SAMSUNG BIOLOGICS Co., Ltd. stock forecast: see what analysts think of SAMSUNG BIOLOGICS Co., Ltd. and suggest that you do with its stocks.
207940 reached its all-time high on Oct 28, 2025 with the price of 1,946,000 KRW, and its all-time low was 191,000 KRW and was reached on Nov 10, 2016. View more price dynamics on 207940 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
207940 stock is 4.30% volatile and has beta coefficient of 0.38. Track SAMSUNG BIOLOGICS Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is SAMSUNG BIOLOGICS Co., Ltd. there?
Today SAMSUNG BIOLOGICS Co., Ltd. has the market capitalization of 80.22 T, it has increased by 7.51% over the last week.
Yes, you can track SAMSUNG BIOLOGICS Co., Ltd. financials in yearly and quarterly reports right on TradingView.
SAMSUNG BIOLOGICS Co., Ltd. is going to release the next earnings report on Jan 28, 2026. Keep track of upcoming events with our Earnings Calendar.
207940 earnings for the last quarter are 11.88 K KRW per share, whereas the estimation was 11.18 K KRW resulting in a 6.22% surprise. The estimated earnings for the next quarter are 10.26 K KRW per share. See more details about SAMSUNG BIOLOGICS Co., Ltd. earnings.
SAMSUNG BIOLOGICS Co., Ltd. revenue for the last quarter amounts to 1.66 T KRW, despite the estimated figure of 1.59 T KRW. In the next quarter, revenue is expected to reach 1.62 T KRW.
207940 net income for the last quarter is 574.46 B KRW, while the quarter before that showed 324.39 B KRW of net income which accounts for 77.09% change. Track more SAMSUNG BIOLOGICS Co., Ltd. financial stats to get the full picture.
No, 207940 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2025, the company has 5.01 K employees. See our rating of the largest employees — is SAMSUNG BIOLOGICS Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAMSUNG BIOLOGICS Co., Ltd. EBITDA is 2.69 T KRW, and current EBITDA margin is 42.20%. See more stats in SAMSUNG BIOLOGICS Co., Ltd. financial statements.
Like other stocks, 207940 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAMSUNG BIOLOGICS Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAMSUNG BIOLOGICS Co., Ltd. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAMSUNG BIOLOGICS Co., Ltd. stock shows the strong buy signal. See more of SAMSUNG BIOLOGICS Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.